Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP889423.RAC6IpnaU2aiZLNnIXHMKsxT2i_X0ZGi4nelJc9ULIdOc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP889423.RAC6IpnaU2aiZLNnIXHMKsxT2i_X0ZGi4nelJc9ULIdOc130_assertion type Assertion NP889423.RAC6IpnaU2aiZLNnIXHMKsxT2i_X0ZGi4nelJc9ULIdOc130_head.
- NP889423.RAC6IpnaU2aiZLNnIXHMKsxT2i_X0ZGi4nelJc9ULIdOc130_assertion description "[In the high platelet group, 5- and 10-year carcinogenesis rates were 3.7% and 8.3% in the IFN-treated group (N=228) and 5.1% and 14.0% in the untreated group (N=585), respectively (P=.69).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP889423.RAC6IpnaU2aiZLNnIXHMKsxT2i_X0ZGi4nelJc9ULIdOc130_provenance.
- NP889423.RAC6IpnaU2aiZLNnIXHMKsxT2i_X0ZGi4nelJc9ULIdOc130_assertion evidence source_evidence_literature NP889423.RAC6IpnaU2aiZLNnIXHMKsxT2i_X0ZGi4nelJc9ULIdOc130_provenance.
- NP889423.RAC6IpnaU2aiZLNnIXHMKsxT2i_X0ZGi4nelJc9ULIdOc130_assertion SIO_000772 19375558 NP889423.RAC6IpnaU2aiZLNnIXHMKsxT2i_X0ZGi4nelJc9ULIdOc130_provenance.
- NP889423.RAC6IpnaU2aiZLNnIXHMKsxT2i_X0ZGi4nelJc9ULIdOc130_assertion wasDerivedFrom befree-20140225 NP889423.RAC6IpnaU2aiZLNnIXHMKsxT2i_X0ZGi4nelJc9ULIdOc130_provenance.
- NP889423.RAC6IpnaU2aiZLNnIXHMKsxT2i_X0ZGi4nelJc9ULIdOc130_assertion wasGeneratedBy ECO_0000203 NP889423.RAC6IpnaU2aiZLNnIXHMKsxT2i_X0ZGi4nelJc9ULIdOc130_provenance.